|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 16
2022
Christopoulos, Petros; Kluck, Klaus; Kirchner, Martina; Lueders, Heike; Roeper, Julia; Falkenstern-Ge, Roger-Fei; Szewczyk, Marlen; Sticht, Florian; Saalfeld, Felix C.; Wesseler, Claas; Hackanson, Bjoern; Dintner, Sebastian; Faehling, Martin; Kuon, Jonas; Janning, Melanie; Kauffmann-Guerrero, Diego; Kazdal, Daniel; Kurz, Sylke; Eichhorn, Florian; Bozorgmehr, Farastuk; Shah, Rajiv; Tufman, Amanda; Wermke, Martin; Loges, Sonja; Brueckl, Wolfgang M.; Schulz, Christian; Misch, Daniel; Frost, Nikolaj; Kollmeier, Jens; Reck, Martin; Griesinger, Frank; Grohe, Christian; Hong, Jin-Liern; Lin, Huamao M.; Budczies, Jan; Stenzinger, Albrecht und Thomas, Michael
(2022):
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
In: European Journal of Cancer, Bd. 170: S. 106-118
2021
Brueckl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Stenzinger, Albrecht; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2021):
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
In: Translational Lung Cancer Research, Bd. 10, Nr. 7: S. 3093-3106
Budczies, Jan; Kirchner, Martina; Kluck, Klaus; Kazdal, Daniel; Glade, Julia; Allgaeuer, Michael; Kriegsmann, Mark; Heussel, Claus-Peter; Herth, Felix J.; Winter, Hauke; Meister, Michael; Muley, Thomas; Goldmann, Torsten; Froehling, Stefan; Wermke, Martin; Waller, Cornelius F.; Tufman, Amanda; Reck, Martin; Peters, Solange; Schirmacher, Peter; Thomas, Michael; Christopoulos, Petros und Stenzinger, Albrecht
(2021):
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
In: Cancer Immunology Immunotherapy, Bd. 71, Nr. 2: S. 251-265
Dempke, Wolfram C. M. und Reck, Martin
(2021):
KEAP1/NRF2 (NFE2L2) mutations in NSCLC-Fuel for a superresistant phenotype?
In: Lung Cancer, Bd. 159: S. 10-17
Kazdal, Daniel; Rempel, Eugen; Oliveira, Cristiano; Allgaeuer, Michael; Harms, Alexander; Singer, Kerstin; Kohlwes, Elke; Ormanns, Steffen; Fink, Ludger; Kriegsmann, Joerg; Leichsenring, Michael; Kriegsmann, Katharina; Stoegbauer, Fabian; Tavernar, Luca; Leichsenring, Jonas; Volckmar, Anna-Lena; Longuespee, Remi; Winter, Hauke; Eichhorn, Martin; Heussel, Claus Peter; Herth, Felix; Christopoulos, Petros; Reck, Martin; Muley, Thomas; Weichert, Wilko; Budczies, Jan; Thomas, Michael; Peters, Solange; Warth, Arne; Schirmacher, Peter; Stenzinger, Albrecht und Kriegsmann, Mark
(2021):
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma.
In: Translational Lung Cancer Research, Bd. 10, Nr. 4: S. 1666-1678
2020
Kobold, Sebastian und Reck, Martin
(2020):
Interleukin-1β und pro-tumorale Inflammation – Zentrale Faktoren bei der Entstehung von Krebserkrankungen.
In: Oncology Research and Treatment, Bd. 43, Nr. SUPPL 3: S. 6-12
Brückl, Wolfgang M.; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H.; Christopoulos, Petros; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H. und Laack, Eckart
(2020):
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
In: Clinical Medicine Insights-Oncology, Bd. 14: S. 1-9
[PDF, 433kB]
Wessels, Sabine; Muley, Thomas; Christopoulos, Petros; Meister, Michael; Heinzmann-Groth, Ingrid; Warth, Arne; Herpel, Esther; Hummler, Simone; Klingmüller, Ursula; Kuon, Jonas; Heussel, Claus-Peter; Eberhardt, Ralf; Herth, Felix J. F.; Winter, Hauke; Bischoff, Helge; Stenzinger, Albrecht; Reck, Martin; Huber, Rudolf Maria; Thomas, Michael und Schneider, Marc A.
(2020):
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives.
In: Translational Lung Cancer Research, Bd. 9, Nr. 4: S. 1000-1014
2019
Reck, Martin; Kerr, Keith M.; Grohe, Christian; Manegold, Christian; Pavlakis, Nick; Paz-Ares, Luis; Huber, Rudolf M.; Popat, Sanjay; Thatcher, Nick; Park, Keunchil; Hilberg, Frank; Barrueco, Jose und Kaiser, Rolf
(2019):
Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
In: Future Oncology, Bd. 15, Nr. 12: S. 1363-1383
2017
Manegold, Christian; Dingemans, Anne-Marie C.; Gray, Jhanelle E.; Nakagawa, Kazuhiko; Nicolson, Marianne; Peters, Solange; Reck, Martin; Wu, Yi-Long; Brustugun, Odd Terje; Crinò, Lucio; Felip, Enriqueta; Fennell, Dean; Garrido, Pilar; Huber, Rudolf M.; Marabelle, Aurélien; Moniuszko, Marcin; Mornex, Francoise; Novello, Silvia; Papotti, Mauro; Pérol, Maurice; Smit, Egbert F.; Syrigos, Kostas; Meerbeeck, Jan P. van; Zandwijk, Nico van; Yang, James Chih-Hsin; Zhou, Caicun und Vokes, Everett
(2017):
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC.
In: Journal of thoracic Oncology, Bd. 12, Nr. 2: S. 194-207
2016
Ilhan-Mutlu, Aysegül; Osswald, Matthias; Liao, Yunxiang; Gömmel, Miriam; Reck, Martin; Miles, David; Mariani, Paola; Gianni, Luca; Lutiger, Beatrix; Nendel, Viktor; Srock, Stefanie; Perez-Moreno, Pablo; Thorsen, Frits; Baumgarten, Louisa von; Preusser, Matthias; Wick, Wolfgang und Winkler, Frank
(2016):
Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma.
In: Molecular Cancer therapeutics, Bd. 15, Nr. 4: S. 702-710
2014
Gaber, Rania; Watermann, Iris; Kugler, Christian; Reinmuth, Nils; Huber, Rudolf M.; Schnabel, Philipp A.; Vollmer, Ekkehard; Reck, Martin und Goldmann, Torsten
(2014):
Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC.
In: Diagnostic Pathology
9:165
[PDF, 2MB]
2011
Armbrecht, Axel; Gröschel, Andreas; Pöttgen, Christoph; Reck, Martin; Rüffer, Jens Ulrich; Seifart, Ulf; Ulrich, Cornelia M. und Winter, Hauke
(2011):
Nachsorge, Komplikationen und deren Therapie bei der operativen, strahlentherapeutischen und medikamentösen Therapie des Lungenkarzinoms.
In: Onkologie, Nr. Suppl.: S. 11-16
[PDF, 358kB]
2010
Dickgreber, Nicolas; Huber, Rudolf M.; Reck, Martin; Reinmuth, Niels; Schütte, Wolfgang; Serke, Monika und Wolf, Jürgen
(2010):
Aktuelle Entwicklungen und Perspektiven zielgerichteter Therapien.
In: Onkologie, Nr. 5: S. 2-11
[PDF, 653kB]
2009
Diederich, Stefan; Engeser, Peter; Junker, Klaus; Passlick, Bernward; Pfluger, Thomas; Pöttgen, Christoph und Reck, Martin
(2009):
Beurteilung des Therapieerfolgs – konventionelle versus neue Methoden.
In: Onkologie: S. 9-17
[PDF, 280kB]
2006
Deppermann, Karl-Matthias; Huber, Rudolf M.; Laack, Eckart; Reck, Martin; Serke, Monika und Pawel, Joachim
(2006):
Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im Stadium IV.
In: Onkologie, Nr. 2: S. 15-19
[PDF, 194kB]